
MHRA appoints three directors to its Board
pharmafile | July 31, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | DoH, MHRA
The Department of Health has announced that three new non-executive directors are joining the Medicines and Healthcare Products Regulatory Agency.
The three directors joining the MHRA are: Dame Valerie Beral, director of the Cancer Epidemiology Unit at the University of Oxford; Professor Alexander Markham, Professor of Medicine at the University of Leeds; and Professor David Webb (pictured), Christison Professor of Therapeutics and Clinical Pharmacology at the University of Edinburgh.
MHRA incorporates the Clinical Practice Research Datalink (CPRD), an e-health research service and the National Institute for Biological Standards and Control (NISBC), which assures the standards of biological medicines.
Lord Howe, health minister, said: “I am pleased to appoint Dame Valerie Beral, Professor Alexander Markham and Professor David Webb as non-executive directors of the MHRA. They bring a wealth of experience to our board and will play a key role in the leadership of the agency in its vital role, improving and protecting public health.”
Related Content

MHRA to establish Northern Ireland hub for life sciences sector
The Medicines and Healthcare products Regulatory Agency (MHRA) is establishing a new hub in Northern …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

IMed Consultancy releases white paper on Digital Mental Health Technologies
IMed Consultancy, a consultancy and service provider for the medical and health technology sector, has …





